Echocardiographic Parameters During and Beyond Onset of Kawasaki Disease Correlate with Onset Serum N-Terminal pro-Brain Natriuretic Peptide (NT-proBNP)

被引:0
作者
Laurent Desjardins
Audrey Dionne
Léamarie Meloche-Dumas
Anne Fournier
Nagib Dahdah
机构
[1] Université de Montréal,Division of Pediatric Cardiology, CHU Mère
[2] Dalhousie University,Enfant Ste
[3] Harvard Medical School,Justine
来源
Pediatric Cardiology | 2020年 / 41卷
关键词
Kawasaki disease; Vasculitis; NTpro-BNP; Biomarker; Systolic and diastolic function;
D O I
暂无
中图分类号
学科分类号
摘要
The N-terminal proBNP (NT-proBNP), produced by cardiomyocytes, has several reported utilities and associations in acute Kawasaki disease (KD). The objective of this study is to examine the relationship between serum values of NT-proBNP at time of KD diagnosis with cardiac systolic, diastolic function and electrocardiographic changes, at onset of the disease and during the first year of follow-up. KD was diagnosed in 127 children between March 2007 and July 2014, mean diagnostic age 3.5 ± 2.9 years. Coronary artery maximum z score was 2.6 ± 2.8 (range − 0.6 to + 18.9), with giant aneurysm in 5/122 (4.1%). Age-adjusted NT-proBNP was 2.6 ± 1.6 z score, 78/122 (63.9%) > 2.0. There was a crescendo correlation between onset NT-proBNP z score and C-Reactive protein (CRP) serum levels (slope + 0.49, p < 0.001). There was a crescendo correlation between NT-proBNP z score and indexed left ventricular (LV) mass (slope + 1.86, p = 0.02), LV diastolic function parameter E/e′ ratio (slope + 0.31, p = 0.04) and a decrescendo correlation with age-adjusted LV shortening fraction (SF) (− 0.63, p = 0.02). Lower SF z score, higher left ventricular mass index and E/e′ ratio were associated with higher NT-proBNP z score, but without correlation with CRP levels. Within 2–3 months from the onset of the disease, there was a resolution of the systolic dysfunction. Electrocardiographic parameter changes were associated with decreased LV shortening fraction but not with NT-proBNP. KD patients with elevated NT-proBNP at onset have sub-clinical myocardial involvement and might benefit from follow-up and continued evaluation, even in the absence of coronary artery involvement.
引用
收藏
页码:947 / 954
页数:7
相关论文
共 288 条
[11]  
Gewitz M(2000)Normal values of M mode echocardiographic measurements of more than 2000 healthy infants and children in central Europe Heart 83 667-107
[12]  
Baker AL(1978)Pathology of the heart in Kawasaki disease Pediatrics 61 100-592
[13]  
Jackson MA(1980)Histopathological study on right endomyocardial biopsy of Kawasaki disease Br Heart J 43 589-27
[14]  
Takahashi M(1999)Ultrastructural characteristics of myocardial and coronary microvascular lesions in Kawasaki disease Microvasc Res 58 10-35
[15]  
Shah PB(2018)Histopathological aspects of cardiovascular lesions in Kawasaki disease Int J Rheum Dis 21 31-1798
[16]  
Kobayashi T(2016)Myocardial strain and strain rate in Kawasaki disease: range, recovery, and relationship to systemic inflammation/coronary artery dilation J Clin Exp Cardiol 7 432-53
[17]  
Wu MH(2013)The emerging role of cardiovascular magnetic resonance in the evaluation of Kawasaki disease Int J Cardiovasc Imaging 29 1787-92
[18]  
Saji TT(2009)Cardiovascular magnetic resonance imaging reveals myocardial inflammation and coronary artery ectasia during the acute phase of Kawasaki disease Int J Cardiol 136 e51-69
[19]  
Pahl E(2011)Noncoronary cardiac abnormalities are associated with coronary artery dilation and with laboratory inflammatory markers in acute Kawasaki disease J Am Coll Cardiol 57 86-115
[20]  
Lin KH(2003)Usefulness of Tc-99m HMPAO-labeled WBC heart scan to predict impaired ventricular function and coronary artery dilation in children with Kawasaki disease Int J Cardiol 92 65-1246